These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

782 related items for PubMed ID: 7704571

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Sites of phosphorylation in tau and factors affecting their regulation.
    Anderton BH, Betts J, Blackstock WP, Brion JP, Chapman S, Connell J, Dayanandan R, Gallo JM, Gibb G, Hanger DP, Hutton M, Kardalinou E, Leroy K, Lovestone S, Mack T, Reynolds CH, Van Slegtenhorst M.
    Biochem Soc Symp; 2001; (67):73-80. PubMed ID: 11447841
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Stimulation of MAP kinase by v-raf transformation of fibroblasts fails to induce hyperphosphorylation of transfected tau.
    Latimer DA, Gallo JM, Lovestone S, Miller CC, Reynolds CH, Marquardt B, Stabel S, Woodgett JR, Anderton BH.
    FEBS Lett; 1995 May 22; 365(1):42-6. PubMed ID: 7774712
    [Abstract] [Full Text] [Related]

  • 6. Physiology and pathology of tau protein kinases in relation to Alzheimer's disease.
    Imahori K, Uchida T.
    J Biochem; 1997 Feb 22; 121(2):179-88. PubMed ID: 9089387
    [Abstract] [Full Text] [Related]

  • 7. Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase.
    Hanger DP, Hughes K, Woodgett JR, Brion JP, Anderton BH.
    Neurosci Lett; 1992 Nov 23; 147(1):58-62. PubMed ID: 1336152
    [Abstract] [Full Text] [Related]

  • 8. Overexpressed tau protein in cultured cells is phosphorylated without formation of PHF: implication of phosphoprotein phosphatase involvement.
    Baum L, Seger R, Woodgett JR, Kawabata S, Maruyama K, Koyama M, Silver J, Saitoh T.
    Brain Res Mol Brain Res; 1995 Dec 01; 34(1):1-17. PubMed ID: 8750856
    [Abstract] [Full Text] [Related]

  • 9. Characterization of tau phosphorylation in glycogen synthase kinase-3beta and cyclin dependent kinase-5 activator (p23) transfected cells.
    Michel G, Mercken M, Murayama M, Noguchi K, Ishiguro K, Imahori K, Takashima A.
    Biochim Biophys Acta; 1998 Apr 10; 1380(2):177-82. PubMed ID: 9565682
    [Abstract] [Full Text] [Related]

  • 10. Glycogen synthase kinase-3 beta phosphorylates tau protein at multiple sites in intact cells.
    Sperber BR, Leight S, Goedert M, Lee VM.
    Neurosci Lett; 1995 Sep 08; 197(2):149-53. PubMed ID: 8552282
    [Abstract] [Full Text] [Related]

  • 11. tau kinases in the rat heat shock model: possible implications for Alzheimer disease.
    Shanavas A, Papasozomenos SC.
    Proc Natl Acad Sci U S A; 2000 Dec 19; 97(26):14139-44. PubMed ID: 11121021
    [Abstract] [Full Text] [Related]

  • 12. Distribution of active glycogen synthase kinase 3beta (GSK-3beta) in brains staged for Alzheimer disease neurofibrillary changes.
    Pei JJ, Braak E, Braak H, Grundke-Iqbal I, Iqbal K, Winblad B, Cowburn RF.
    J Neuropathol Exp Neurol; 1999 Sep 19; 58(9):1010-9. PubMed ID: 10499443
    [Abstract] [Full Text] [Related]

  • 13. Sequential phosphorylation of Tau by glycogen synthase kinase-3beta and protein kinase A at Thr212 and Ser214 generates the Alzheimer-specific epitope of antibody AT100 and requires a paired-helical-filament-like conformation.
    Zheng-Fischhöfer Q, Biernat J, Mandelkow EM, Illenberger S, Godemann R, Mandelkow E.
    Eur J Biochem; 1998 Mar 15; 252(3):542-52. PubMed ID: 9546672
    [Abstract] [Full Text] [Related]

  • 14. Phosphorylation sites on tau identified by nanoelectrospray mass spectrometry: differences in vitro between the mitogen-activated protein kinases ERK2, c-Jun N-terminal kinase and P38, and glycogen synthase kinase-3beta.
    Reynolds CH, Betts JC, Blackstock WP, Nebreda AR, Anderton BH.
    J Neurochem; 2000 Apr 15; 74(4):1587-95. PubMed ID: 10737616
    [Abstract] [Full Text] [Related]

  • 15. The active form of glycogen synthase kinase-3beta is associated with granulovacuolar degeneration in neurons in Alzheimer's disease.
    Leroy K, Boutajangout A, Authelet M, Woodgett JR, Anderton BH, Brion JP.
    Acta Neuropathol; 2002 Feb 15; 103(2):91-9. PubMed ID: 11810173
    [Abstract] [Full Text] [Related]

  • 16. Protein kinase FA/GSK-3 phosphorylates tau on Ser235-Pro and Ser404-Pro that are abnormally phosphorylated in Alzheimer's disease brain.
    Yang SD, Song JS, Yu JS, Shiah SG.
    J Neurochem; 1993 Nov 15; 61(5):1742-7. PubMed ID: 8228990
    [Abstract] [Full Text] [Related]

  • 17. Testosterone prevents the heat shock-induced overactivation of glycogen synthase kinase-3 beta but not of cyclin-dependent kinase 5 and c-Jun NH2-terminal kinase and concomitantly abolishes hyperphosphorylation of tau: implications for Alzheimer's disease.
    Papasozomenos SCh, Shanavas A.
    Proc Natl Acad Sci U S A; 2002 Feb 05; 99(3):1140-5. PubMed ID: 11805297
    [Abstract] [Full Text] [Related]

  • 18. Protein kinase FA/glycogen synthase kinase-3 alpha after heparin potentiation phosphorylates tau on sites abnormally phosphorylated in Alzheimer's disease brain.
    Yang SD, Yu JS, Shiah SG, Huang JJ.
    J Neurochem; 1994 Oct 05; 63(4):1416-25. PubMed ID: 7931292
    [Abstract] [Full Text] [Related]

  • 19. PHF-tau from Alzheimer's brain comprises four species on SDS-PAGE which can be mimicked by in vitro phosphorylation of human brain tau by glycogen synthase kinase-3 beta.
    Mulot SF, Hughes K, Woodgett JR, Anderton BH, Hanger DP.
    FEBS Lett; 1994 Aug 08; 349(3):359-64. PubMed ID: 8050597
    [Abstract] [Full Text] [Related]

  • 20. Tau therapeutic strategies for the treatment of Alzheimer's disease.
    Churcher I.
    Curr Top Med Chem; 2006 Aug 08; 6(6):579-95. PubMed ID: 16712493
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.